Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 6343

1.

Biomarkers in psoriatic arthritis: recent progress.

Chandran V, Scher JU.

Curr Rheumatol Rep. 2014 Nov;16(11):453. doi: 10.1007/s11926-014-0453-4.

PMID:
25218735
[PubMed - in process]
2.

Ustekinumab for the treatment of psoriatic arthritis: an update.

Davari P, Leo MS, Kamangar F, Fazel N.

Clin Cosmet Investig Dermatol. 2014 Sep 2;7:243-9. doi: 10.2147/CCID.S50003. eCollection 2014. Review.

PMID:
25214798
[PubMed]
Free PMC Article
3.

Progress of biological agents on psoriatic arthritis.

Li Y, Wang D, Wang Y, Shi G.

Curr Pharm Biotechnol. 2014;15(6):525-34.

PMID:
25213361
[PubMed - in process]
4.

Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review.

Zhang CS, Yu JJ, Parker S, Zhang AL, May B, Lu C, Xue CC.

Int J Dermatol. 2014 Sep 10. doi: 10.1111/ijd.12607. [Epub ahead of print]

PMID:
25208594
[PubMed - as supplied by publisher]
5.

The panoply of αβT cells in the skin.

Nomura T, Kabashima K, Miyachi Y.

J Dermatol Sci. 2014 Oct;76(1):3-9. doi: 10.1016/j.jdermsci.2014.07.010. Epub 2014 Aug 12. Review.

PMID:
25190363
[PubMed - as supplied by publisher]
6.

Combined Use of Systemic Agents for Psoriasis: A Systematic Review.

Busard C, Zweegers J, Limpens J, Langendam M, Spuls PI.

JAMA Dermatol. 2014 Sep 3. doi: 10.1001/jamadermatol.2014.1111. [Epub ahead of print]

PMID:
25188393
[PubMed - as supplied by publisher]
7.

Developments in clinical trials: A Pharma Matters report.

Arjona A, Nuskey B, Rabasseda X, Arias E.

Drugs Today (Barc). 2014 Aug;50(8):567-77. doi: 10.1358/dot.2014.50.8.2217229.

PMID:
25187907
[PubMed - in process]
8.

Association of rheumatoid factor and uric Acid with psoriatic arthritis: a review.

Khondker L, Khan SI.

Mymensingh Med J. 2014 Jul;23(3):609-13.

PMID:
25178623
[PubMed - in process]
9.

Clinical characteristics and risk factors for low dose methotrexate toxicity: A cohort of 28 patients.

Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H.

Autoimmun Rev. 2014 Aug 27. pii: S1568-9972(14)00171-2. doi: 10.1016/j.autrev.2014.08.027. [Epub ahead of print] Review.

PMID:
25172240
[PubMed - as supplied by publisher]
10.

Cytokines as therapeutic targets in skin inflammation.

Wittmann M, McGonagle D, Werfel T.

Cytokine Growth Factor Rev. 2014 Aug 1. pii: S1359-6101(14)00070-7. doi: 10.1016/j.cytogfr.2014.07.008. [Epub ahead of print]

PMID:
25164568
[PubMed - as supplied by publisher]
11.

IL-21 as a therapeutic target in inflammatory disorders.

Di Fusco D, Izzo R, Figliuzzi MM, Pallone F, Monteleone G.

Expert Opin Ther Targets. 2014 Aug 27:1-10. [Epub ahead of print]

PMID:
25162763
[PubMed - as supplied by publisher]
13.

Relationships between Adipose Tissue and Psoriasis, with or without Arthritis.

Toussirot E, Aubin F, Dumoulin G.

Front Immunol. 2014 Aug 12;5:368. doi: 10.3389/fimmu.2014.00368. eCollection 2014. Review.

PMID:
25161652
[PubMed]
Free PMC Article
14.

The effect of the novel tellurium compound AS101 on autoimmune diseases.

Halpert G, Sredni B.

Autoimmun Rev. 2014 Aug 19. pii: S1568-9972(14)00147-5. doi: 10.1016/j.autrev.2014.08.003. [Epub ahead of print] Review.

PMID:
25153485
[PubMed - as supplied by publisher]
15.

Percutaneous absorption of water in skin: a review.

Blattner CM, Coman G, Blickenstaff NR, Maibach HI.

Rev Environ Health. 2014 Aug 5. pii: /j/reveh.ahead-of-print/reveh-2014-0045/reveh-2014-0045.xml. doi: 10.1515/reveh-2014-0045. [Epub ahead of print]

PMID:
25153208
[PubMed - as supplied by publisher]
16.

Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis.

Al-Badri MR, Azar ST.

Ther Adv Endocrinol Metab. 2014 Apr;5(2):34-8. doi: 10.1177/2042018814543483. Review.

PMID:
25152810
[PubMed]
Free PMC Article
17.

Topical Therapies in Hyperhidrosis Care.

Pariser DM, Ballard A.

Dermatol Clin. 2014 Oct;32(4):485-490. doi: 10.1016/j.det.2014.06.008. Epub 2014 Jul 29. Review.

PMID:
25152341
[PubMed - as supplied by publisher]
18.

Accumulating Evidence for the Association and Shared Pathogenic Mechanisms between Psoriasis and Cardiovascular-Related Co-morbidities.

Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, Tebbey PW, Kimball AB.

Am J Med. 2014 Aug 19. pii: S0002-9343(14)00688-3. doi: 10.1016/j.amjmed.2014.08.008. [Epub ahead of print] Review.

PMID:
25149424
[PubMed - as supplied by publisher]
19.

Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management.

Kasiraman V, Atwan AA, Durojaiye OC, Kalavala M, Piguet V.

Dermatol Online J. 2014 Aug 17;20(8). pii: http://www.escholarship.org/uc/item/8s09h73j.

PMID:
25148273
[PubMed - in process]
20.

Social impact of the burden of psoriasis: effects on patients and practice.

Feldman SR, Malakouti M, Koo JY.

Dermatol Online J. 2014 Aug 17;20(8). pii: http://www.escholarship.org/uc/item/48r4w8h2.

PMID:
25148272
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk